pyridoxal has been researched along with Coronary Disease in 1 studies
Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Serfontein, WJ | 1 |
| Ubbink, JB | 1 |
| De Villiers, LS | 1 |
| Becker, PJ | 1 |
1 other study available for pyridoxal and Coronary Disease
| Article | Year |
|---|---|
Depressed plasma pyridoxal-5'-phosphate levels in tobacco-smoking men.
Topics: Adult; Age Factors; Arteriosclerosis; Coronary Disease; Humans; Male; Middle Aged; Pyridoxal; Pyrido | 1986 |